EICHORCondition: SARS-CoV2 · COVID-19 · Sponsor: Vaxart
The primary objective of the study is to determine the relative efficacy of the investigational oral severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) vaccine tablet VXA-CoV2-3.3 compared to a currently recommended vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19). In order to represent a more recently circulating SARS-CoV-2 variant, the main study endpoints will now evaluate the VXA-CoV2-3.3 (KP.2 strain) vaccine, and not the VXA-CoV2-3.1 (XBB.1.5 strain) vaccine.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Pinnacle Research Group | Anniston, Alabama, United States | — |
| Core Clinical Trials - Central Alabama Research LLC | Birmingham, Alabama, United States | — |
| Coastal Clinical Research | Mobile, Alabama, United States | — |
| Avacare - Lenzmeier Family Medicine | Glendale, Arizona, United States | — |
| Desert Clinical Research | Mesa, Arizona, United States | — |
| Velocity Clinical Research - MedPharmics - Phoenix | Phoenix, Arizona, United States | — |
| Foothills Research Center | Phoenix, Arizona, United States | — |
| Avacare (CCT) - Fiel Family & Sports Medicine | Tempe, Arizona, United States | — |
| Baptist Health Center for Clinical Research - Little Rock | Little Rock, Arkansas, United States | — |
| Elligo Health Research (BTC/ClinEdge) - Core Healthcare Group | Cerritos, California, United States | — |
| Velocity Clinical Research - Chula Vista (eStudySite - Chula Vista) | Chula Vista, California, United States | — |
| Avacare - Benchmark Research - SOCAL-Colton | Colton, California, United States | — |
+ 133 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06672055